insights_auto
Why is SDZNY up 2,14%?
Dive Deeperchevron_right
SDZNY:OTCMKTS
SANDOZ GROUP ADR
92,98 $
arrow_upward
+2,14%(+1,94) 1D
16 հոկ, 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SDZNY...
Open
92,15 $
High
93,52 $
Low
92,15 $
Mkt. cap
33,64 մլրդ
Avg. vol.
27,16 հզր
Volume
24,96 հզր
52-wk high
94,15 $
52-wk low
60,40 $
Shares outstanding
440,00 մլն
No. of employees
20 հզր
Open
92,15 $
High
93,52 $
Low
92,15 $
Mkt. cap
33,64 մլրդ
Avg. vol.
27,16 հզր
Volume
24,96 հզր
52-wk high
94,15 $
52-wk low
60,40 $
Shares outstanding
440,00 մլն
No. of employees
20 հզր
News stories
From web sources and news partners
Yahoo Finance
·
55 րոպե առաջ
Michael Burry Warns Stock Market Could Be Months Away From A 2000-Style Reckoning — ‘The Preconditions Seem Set For Fireworks’
Simply Wall Street
·
6 րոպե առաջ
What Diamondback Energy Holders Bought Into
AOL.com
·
54 րոպե առաջ
Moderna Just Joined the Nasdaq-100. Here's What That Means for Investors.
Profile
Sandoz Group AG is a Swiss company that focuses on generic pharmaceuticals and biosimilars. Prior to October 2023, it was part of a division of Novartis that was established in 2003, when Novartis united all of its generics businesses under the name Sandoz. Before this, the company existed as an independent pharmaceutical manufacturer until 1996, when it was merged with Ciba-Geigy to form Novartis. Prior to the merger, it specialized in medicines used in organ transplants, such as Sandimmune, and various antipsychotics and migraine medicines. Its headquarters were in Holzkirchen, Germany and after the spin-off from Novartis, the headquarters moved to Basel, Switzerland, with most of global functions operating from Holzkirchen in Germany, Prague in Czechia, and Barcelona in Spain. Sandoz is the global leader in generic pharmaceuticals and biosimilars. Wikipedia
About SANDOZ GROUP ADR